Pfizer has confirmed that it will begin using its facility in County Dublin as part of its supply chain for its Covid-19 vaccine.
Pfizer’s Dublin facility is located in Grange Castle and will be used to produce a component of the vaccine by the end of this year. It’s reported that it will be an mRNA substance to aid the manufacture outside of Ireland.
The decision will create 75 new jobs and will see Pfizer make a $40m investment in their Dublin site.
The announcement made today reads, “These enhancements include expanding their existing facilities, adding more suppliers, and bringing on additional Pfizer/BioNTech sites and contract manufacturers around the world to produce the vaccine.
“As such, Pfizer is now bringing on additional European-based facility to be a part of the global Pfizer-BioNTech Covid-19 vaccine supply chain network and Grange Castle (Ireland) will contribute to the worldwide supply of the vaccine.
“Pfizer’s Grange Castle facility will produce mRNA drug substance. Given the extensive technical transfer process, on-site development, equipment installation and regulatory approvals needed for the sites, we expect both facilities will be brought onto the network by the end of 2021.”
The pharmaceutical giant started distributing their Covid-19 vaccine in December 2020.
READ NEXT: New estimated date for indoor dining and guidelines for outdoor dining revealed this morning
